1. Introduction
===============

Coronaviruses possess the largest genome among any RNA viruses. The genome contains several essential genes that encode the viral proteins necessary for replication, transcription and infectious virus assembly. The essential genes comprise the open reading frames 1a and 1b (ORF1ab) that are translated to produce polyproteins that are involved in viral RNA replication and transcription. In addition to these genes, the other essential genes encode the common viral structural proteins, S, E, M and N, which are involved in infectious virus assembly ([Fig. 1](#fig1){ref-type="fig"} ). Interspersed between these genes in the coronavirus genome are several other genes called "group-specific or accessory genes" and their gene products are called "accessory proteins" because many studies using reverse genetics and targeted mutagenesis analysis have shown that these genes and their products are dispensable for virus growth in vitro ([@bib4], [@bib5], [@bib13], [@bib46], [@bib59], [@bib61]). Nevertheless, many of these genes are still maintained in the virus genome suggesting that they might play a very important role in the survival of the virus under the natural environment of the infected host.Fig. 1Genome organization of SARS coronavirus accessory genes. The accessory genes are shown as gray boxes. The ORFs 1a and 1b comprise the SARS-CoV replicase genes. The figure is not drawn to scale. RFS: ribosomal frameshift.

The SARS-CoV genome has an unusually high number of accessory genes in the 3′-end of the genome ([Fig. 1](#fig1){ref-type="fig"}). The genome contains eight accessory genes, two between S and E genes (ORFs 3a and 3b), five are located between the M and N genes (6, 7a, 7b, 8a, 8b) and one within the N gene (9b) ([Fig. 1](#fig1){ref-type="fig"}) ([@bib32], [@bib42]). The sequences of most of these genes are conserved among different human and animal isolates of SARS-CoV. However, as expected, these group-specific genes have no similarity with accessory genes of coronaviruses belonging to other groups ([@bib27]). In addition, there is no significant amino-acid sequence similarity between the accessory proteins encoded by the SARS-CoV accessory genes and any known viral or cellular proteins. The field of coronavirus accessory proteins has gained considerable attention with the advent of SARS epidemic. Several studies, primarily using expression systems in cell culture, have resulted in the discovery of novel functions for the SARS-CoV accessory proteins ([Table 1](#tbl1){ref-type="table"} ). The establishment of reverse genetics system for SARS-CoV has greatly facilitated the studies to determine the biological functions of these proteins in infected cells and/or animals ([@bib2], [@bib60]).Table 1Summary of SARS-CoV accessory proteinsAccessory proteinsIncorporation into virions/VLPsFunction(s)3aYesNF-κβ ↑, JNK ↑, IL-8 ↑, RANTES ↑, ion-channel activity, apoptosis induction and cell cycle arrest.3bUnknownType I IFN production and signaling inhibition, apoptosis induction and cell cycle arrest.ORF6YesType I IFN production and signaling inhibition.7aYesNF-κβ ↑, JNK ↑, p38 MAP kinase ↑, host translation inhibition, apoptosis induction and cell cycle arrest.7bYesNo known function8aUnknownNo known function8bUnknownNo known function9bUnknownNo known function[^3]

In this review, we will (1) summarize the properties, expression and subcellular localization of the individual SARS-CoV accessory proteins in cultured cells, infected cells and/or SARS patients; (2) describe studies identifying the biological function of these proteins; (3) conclude with some points about the potential implications of these discoveries for future studies.

2. SARS-CoV accessory proteins
==============================

2.1. 3a and 3b proteins
-----------------------

SARS-CoV 3a protein is translated from ORF 3a, located between the S and E genes, in the genome ([Fig. 1](#fig1){ref-type="fig"}). As a 274 amino-acid long protein, it is the largest of the SARS-CoV accessory proteins. Hydrophobicity analysis and topology studies have shown that 3a protein is an *O*-glycosylated protein with three transmembrane domains and has an N-terminal ectodomain and a C-terminal endodomain ([@bib20], [@bib37], [@bib47], [@bib53], [@bib62]). Expression studies have shown that the C-terminus of 3a protein has two intracellular protein sorting and trafficking signals, the YxxΦ and di-acidic motifs, which are important for the transport of 3a protein to the cell surface, where it subsequently undergoes endocytosis ([@bib53]). Lu et al. showed that 3a protein forms a homotetramer complex through intermolecular disulfide bridges and functions as a potassium-permeable channel-like structure ([@bib31]). The biological role of the ion channel activity of 3a protein in the virus life cycle remains to be established.

Several studies have examined the properties and subcellular localization of 3a protein. In infected cells, 3a protein is localized in both intracellular and plasma membranes ([@bib20], [@bib37], [@bib47], [@bib53], [@bib62]). Analysis of 3a protein in infected cells and SARS patients suggested that 3a protein might be incorporated into virus particles as a result of its association with S protein ([@bib68]). Biochemical studies examining the interaction of 3a protein with other viral proteins revealed that 3a protein interacts with the structural proteins, S and M, in the Golgi apparatus proximal to the site of virus assembly and budding ([@bib53], [@bib62]). 3a protein also interacts with the structural protein, E, and another viral accessory protein, 7a ([@bib53]). A recent study showed that 3a protein binds to the 5′ untranslated region (UTR) of SARS genomic RNA in vitro ([@bib44]). As expected from its multiple interactions with other viral structural proteins, studies have shown clearly that 3a is a novel viral structural protein ([@bib20], [@bib45]). Several studies have also demonstrated the incorporation of 3a protein into virus-like particles (VLPs), which are produced by co-expression of the virus structural proteins, S, E, M and N ([@bib16], [@bib45]). However, 3a protein is not necessary for VLP formation and SARS-CoV assembly. The production of VLPs in the absence of 3a protein expression clearly demonstrates that 3a protein is not necessary for VLP production; ([@bib14], [@bib15], [@bib18], [@bib35]). Furthermore, the generation of a viable SARS-CoV deletion mutant lacking the 3a gene that replicates efficiently in cell culture also highlights the non-essential function of 3a protein for SARS-CoV assembly in cell culture ([@bib61]).

An interesting feature of 3a protein is the finding that it is released in detergent-resistant membrane structures from SARS-CoV-infected and 3a protein-expressing cells ([@bib16]). The sorting domains, YxxΦ and di-acidic motifs, are not required for its efficient release ([@bib16]). Although the biological role of the released 3a protein in SARS-CoV life cycle remains unclear, some clues into its potential function could be obtained from observations about the highly antigenic nature of 3a protein in SARS patients. In convalescent SARS patients, antibodies against 3a protein are readily detected ([@bib52]). A strong and potentially protective humoral response is directed against the amino terminus of 3a protein in SARS patients ([@bib70]). Furthermore, immunization of rabbits with a synthetic peptide corresponding to the amino acids 15--28 from the amino terminal ectodomain of 3a protein results in the induction of neutralizing antibodies that inhibit SARS-CoV infection in VeroE6 cells ([@bib1]). It is worth speculating the contribution of the released 3a protein as an immune decoy in countering the host humoral response to 3a protein in SARS patients, although any such biological role of 3a protein needs experimental evidence.

Several studies have investigated the biological functions of 3a protein primarily by expression in cell culture models. In vitro expression studies in cultured cells have shown that 3a protein induces G1 phase cell cycle arrest by reducing cyclin D3 expression and inhibiting retinoblastoma protein (Rb) phosphorylation ([@bib67]) and induces apoptosis in Vero E6 cells ([@bib29]). The role of cell cycle arrest and apoptosis in SARS-CoV life cycle is unclear.

The SARS-CoV-induced disease resembles the features of an acute respiratory distress (ARDS) triggered by high levels of pro-inflammatory cytokine and chemokine production. The consensus opinion, from several published studies, is that virus-induced immune pathology and the disease outcome is most probably determined by a dysregulated immune response with an intense up-regulation of pro-inflammatory cytokines and chemokines ([@bib28], [@bib39], [@bib69]). The role of accessory proteins in the up-regulation of pro-inflammatory cytokines and chemokines in SARS-CoV infected cells has received some attention in some recent studies. 3a protein up-regulates the expression and secretion of fibrinogen in human lung epithelial cell line, A549 ([@bib54]). This study also showed the up-regulation of fibrinogen in SARS-CoV-infected Vero E6 cells and the authors conclude that excessive production of fibrinogen might contribute to SARS pathogenesis by enhancing cytokine production ([@bib54]). A recent report showed that the expression of SARS-CoV 3a protein in A549 cells activates the nuclear factor kappa B (NF-κB), a critical transcription factor involved in the activation of pro-inflammatory genes, and c-jun N-terminal kinase (JNK) ([@bib21]). This study also showed that 3a protein expression enhances the activation of the NF-κB-responsive chemokines, interleukin 8 (IL-8) and RANTES (CCL5), which are known to be up-regulated in SARS-CoV infection ([@bib21], [@bib28]).

We have similar data for the role of 3a protein in the induction of NF-κB-promoter activity in vitro. 3a protein expression in HEK 293 cells significantly augmented the activation of NF-κB and RANTES-promoter-driven luciferase reporter gene expression in the presence of double-stranded RNA (dsRNA), an intracellular intermediate of viral RNA replication ([Fig. 2](#fig2){ref-type="fig"}A and B). The enhancement of NF-κB promoter activation in the presence of 3a protein involves an intracellular sensor of dsRNA because transfection of dsRNA into cells is required for the activity of 3a protein ([Fig. 3](#fig3){ref-type="fig"} ). Similarly, SARS-CoV infection in 293/ACE2 cells, stably expressing the SARS-CoV receptor, human angiotensin converting enzyme 2 (ACE2), induces the activation of NF-κB and RANTES promoters, albeit with delayed kinetics compared to the control virus, Sendai virus, which induces a robust activation of NF-κB promoter at earlier times post-infection ([Fig. 4](#fig4){ref-type="fig"} ). In contrast to our finding that showed a significant induction of NF-κB-dependent promoters in SARS-CoV-infected 293/ACE2 cells compared to mock-infected cells, other studies have reported that SARS-CoV infection does not significantly induce NF-κB-promoter-driven gene expression in 293 cells ([@bib8], [@bib48]). In addition, SARS-CoV infection in Vero E6 cells also up-regulates the expression of NFKBIA, an inhibitor of the NF-κB complex ([@bib30]). The discrepancy between these studies and our observation could be attributed to differences in the cell type (highly permissive 293/ACE2 cells; ∼ 80 to 90% infected) and the timing of the assay as we observed a delayed kinetics of NF-κB-dependent promoter activation compared to other studies that examined the induction at earlier times post-infection ([@bib8], [@bib48], [@bib55]).Fig. 23a protein enhances dsRNA-mediated activation of NF-κB-regulated promoters. Human embryonic kidney (HEK) 293 cells were transfected with an NF-κB-driven luciferase (luc) reporter plasmid (A) or a RANTES-luc reporter plasmid (B) for the reporter assays. These cells were co-transfected with one of the indicated SCoV accessory protein expression plasmids, or a control empty vector, pcDNA 3.1 (EV) and a plasmid constitutively expressing β-galactosidase (β-gal) as an internal control. After 24 h post transfection, cells were mock-transfected, or transfected with dsRNA, poly I:C (10 μg/ml), for 6 h. Cell extracts were analyzed for luciferase activities and normalized to β-gal activity to obtain the relative luciferase activity. Triplicate samples were analyzed for each experimental group.Fig. 33a protein-mediated enhancement of NF-κB promoter activation requires intracellular dsRNA. HEK 293 cells were co-transfected with an NF-κB-luc reporter plasmid, β-gal plasmid along with 3a-expression plasmid or empty vector (EV). After 24 h post transfection, the cells were either mock-treated, treated with poly I:C (50 μg/ml) in the media, mock-transfected or transfected with poly I:C (10 μg/ml), for 6 h. Cell extracts were analyzed for luciferase activities and normalized to β-gal activity to obtain the relative luciferase activity. Note that 3a protein enhances the dsRNA-mediated activation of NF-κB promoter only in the dsRNA-transfected samples.Fig. 4SARS-CoV infection induces the activation of NF-κB-regulated promoters. 293/ACE2 cells, stably expressing the SARS-CoV receptor, human angiotensin converting enzyme 2 (ACE2), were transfected with NF-κB-luc reporter plasmid (A and B) or RANTES-luc reporter plasmid (C). After 9 h post transfection, the cells were mock-infected or infected with the Urbani strain of SARS-CoV \[multiplicity of infection (MOI) = 3\] or the control virus, Sendai virus (100 HA units/ml). After 18 h post-infection, RNA was extracted from the cells and luciferase mRNA levels were measured by real-time PCR analysis. The fold change in expression level, compared to mock-infected cells, is shown. The expression levels are normalized to 18S ribosomal RNA. Note the delayed kinetics in up-regulation of NF-κB and RANTES-promoter-driven luc mRNA in SARS-CoV-infected cells compared to Sendai virus infection.

The studies described above only point to a correlation between the observations in 3a-expressing cells and SARS-CoV-infected cells. The precise contribution of 3a protein in exerting these biological functions in infected cells and its role in viral pathogenesis remains unclear and warrants further investigation using deletion mutants of SARS-CoV lacking the 3a gene.

SARS-CoV 3b protein, produced from ORF 3b, is 154-amino acids long and is reported to be localized to the nucleolus and mitochondria in expression studies ([@bib63], [@bib66]). However, a recent study using expression of GFP-tagged proteins showed that 3b protein was localized primarily in the nucleus with no evidence of mitochondrial localization ([@bib24]). Immunohistochemical analysis of SARS-CoV-infected Vero E6 cells showing the presence of 3b protein is the only evidence for the expression of 3b protein in infected cells ([@bib3]).

Expression studies showed that 3b protein induces cell growth arrest in G0/G1 phase ([@bib64]). Another report showed that overexpression of 3b protein induces both apoptosis and necrosis in Vero E6 cells ([@bib23]). 3b protein is dispensable for SARS-CoV replication in cell culture demonstrating its accessory function ([@bib61]). A recent report has assigned a very important function for 3b protein in modulating the host innate immune response to SARS-CoV infection ([@bib24]). This study showed that 3b protein expression inhibits both interferon production and signaling, which are key components of the antiviral innate immune response ([@bib24]). The mechanism of action of 3b protein is still unclear and its interferon inhibitory function in SARS-CoV-infected cells remains to be demonstrated.

2.2. ORF 6 protein
------------------

SARS-CoV ORF 6 protein is a 63-amino-acid, membrane-associated protein and its expression was confirmed in virus-infected Vero E6 cells as well as in the lung and intestine tissues of SARS patients ([@bib10], [@bib38]). It is mainly localized in the endoplasmic reticulum and Golgi compartments in expressing cells ([@bib10], [@bib38]) and virus-infected cells ([@bib9]). ORF 6 protein is incorporated into virus particles and is also released from cells expressing the protein ([@bib17]). While studies have shown that ORF 6 protein is non-essential for SARS-CoV replication in cultured cells and BALB/c mice ([@bib61]), several other studies have also indicated that ORF 6 protein might be involved in viral replication and inhibition of interferon (IFN) pathway ([@bib9], [@bib24], [@bib38]).

In a study using murine coronavirus infection model, it was shown that an attenuated mouse hepatitis coronavirus (MHV) expressing SARS-CoV ORF 6 protein replicated to a higher titer than the parental MHV in cell culture and exhibited increased virulence in mice ([@bib38]). In contrast, expression of each of the other SARS-CoV accessory proteins, 3a, 3b, 7a, 7b, and 8 using recombinant MHV did not affect virus replication and virulence, suggesting that ORF 6 protein might play a role in SARS-CoV pathogenesis. Subsequent studies using recombinant MHV also demonstrated that ORF 6 protein associated with viral RNA, co-localized with replicating viral RNA on cytoplasmic vesicles and enhanced MHV viral RNA and protein synthesis ([@bib56]). Furthermore, studies showing the interaction of ORF 6 protein with SARS-CoV non-structural protein (nsp) 8, one of the replicase proteins encoded in ORF 1a, using a yeast two-hybrid screen and in SARS-CoV-infected cells supports the notion that ORF 6 protein could play a role in virus replication ([@bib26]). While nsp12 protein is the primary RNA-dependent RNA polymerase (RdRp) for SARS-CoV, nsp8 is a second, newly identified sequence-specific RdRp ([@bib19]). It is proposed that nsp8 protein is a low-fidelity primase producing short RNA primers utilized by the primer-dependent nsp12 for initiation of viral RNA replication. Although the biological significance of the reported interaction between ORF 6 protein and nsp8 protein is still unclear, it is reasonable to speculate that ORF 6 protein probably regulates SARS-CoV RNA replication.

A recent study revealed an important function of ORF 6 protein that showed that ORF 6 protein is a type I interferon antagonist targeting multiple steps of the IFN pathway ([@bib9], [@bib24]). This study demonstrated that ORF 6 protein expression suppressed the IFN induction as well as the IFN signaling pathways ([@bib24]).

Further studies revealed the mechanism of action of ORF 6 protein, whereby it interferes with the nuclear translocation of signal transducer and activator of transcription (STAT) 1, a critical player in the IFN signaling pathway ([@bib9]). ORF 6 protein expression blocks the nuclear translocation of STAT1 after IFN treatment indirectly by disrupting the nuclear import complex formation through interaction of ORF 6 protein, via its C-terminus, with karyopherin alpha 2 ([@bib9]). Karyopherin alpha 2 is a member of a complex of nuclear localization signal receptors that includes karyopherin alpha 1 and karyopherin beta 1 ([@bib9]). The authors conclude that ORF 6 protein-mediated inhibition of the expression of STAT1-transcribed, IFN response genes, which is critical for the host to establish the antiviral state, could contribute to the immune evasion by SARS-CoV ([@bib9]).

2.3. 7a and 7b proteins
-----------------------

7a and 7b accessory proteins are produced from the bicistronic subgenomic RNA 7 of SARS-CoV ([@bib32], [@bib42]). The 122-amino-acid SARS-CoV 7a protein is a type I transmembrane protein containing a 15 amino-acid signal peptide sequence, an 81 amino-acid lumenal domain, a 21 amino-acid transmembrane domain and a short C-terminal tail ([@bib36]). The crystal structure of the lumenal domain of 7a protein shows a compact seven-stranded beta sandwich, which is similar in folding and topology to members of the immunoglobulin superfamily ([@bib36]). 7a protein was shown to be present in the perinuclear region in SARS-CoV-infected cells ([@bib6], [@bib7], [@bib36]). There is no consensus opinion in the literature regarding the precise subcellular localization of 7a protein. While some studies have reported the co-localization of 7a protein with the endoplasmic reticulum (ER) marker, GRP94, or the intermediate compartment (ERGIC) marker Sec-31 ([@bib6], [@bib7]), others have shown the co-localization with the *trans*-Golgi marker, Golgin 97 ([@bib36]). Another report showed the presence of 7a protein in the Golgi compartment ([@bib25]).

7a protein is incorporated into purified SARS-CoV particles ([@bib15]). Expression studies have suggested that 7a protein is incorporated into VLPs through its interaction with the viral structural proteins, M and E ([@bib6], [@bib15]). The 7a protein also interacts with 3a protein ([@bib53]) and S protein ([@bib15]); however, these interactions seem to be non-essential for the incorporation of 7a protein into VLPs ([@bib15]).

Several studies have reported diverse biological functions of 7a protein in cultured cells. These include induction of apoptosis in several cell lines through a caspase-dependent pathway ([@bib51]), inhibition of cellular protein synthesis, activation of p38 mitogen-activated protein kinase ([@bib25]) and cell cycle arrest at the G0/G1 phase ([@bib65]). Expressed 7a protein also interacts with small glutamine-rich tetratricopeptide repeat-containing protein with undetermined biological significance ([@bib6]). 7a protein expression also enhances pro-inflammatory cytokine production through the activation of NF-κB and JNK in A549 cells ([@bib21]). It is still unclear whether 7a protein exerts similar functions in virus infection.

The 7b protein, a 44-amino-acid integral membrane protein, is expressed in SARS-CoV-infected cells and is localized in the Golgi compartment ([@bib43]). The detection of anti-7b antibody in SARS patient serum also suggests its expression in infected patients ([@bib12]). 7b protein was found to be associated with intracellular virus particles and also in purified virion ([@bib43]).

Both 7a and 7b proteins are dispensable for virus replication because SARS-CoV mutant lacking the 7a and 7b genes replicated efficiently in cell culture and mice, ([@bib61]), which is also supported by the study showing a 45-nucleotide deletion in ORF 7b gene upon serial passage of SARS-CoV in Vero E6 cells ([@bib57]). Furthermore, Sims et al. showed that ORF 7a/7b can be replaced with the green fluorescent protein (GFP) generating a recombinant virus (SARS-CoV GFP) that replicated as well as wild type virus in several cell lines ([@bib46]) highlighting the accessory nature of 7a and 7b proteins.

2.4. Other SARS-CoV accessory proteins
--------------------------------------

The expression of accessory proteins, 8a and 8b, produced from SARS-CoV subgenomic RNA 8, was confirmed in virus-infected cells ([@bib22]). Epidemiological studies showed that the early human and animal SARS-CoV isolates contained only one intact ORF 8. During the outbreak of SARS in 2003, most human isolates of SARS-CoV had a naturally occurring 29-nt deletion in ORF 8, resulting in two discrete ORFs 8a and 8b ([@bib11]). These observations suggested that the deletion of 29-nt could have some correlation with the adaptation of SARS-CoV to humans during the outbreak. However, insertion of this 29-nt sequence into human isolates using reverse genetics, which merges ORF 8a and 8b into a continuous ORF 8, had little impact on virus growth and RNA replication in cell culture ([@bib61]). This data suggested the 29-nt deletion might not be responsible for the increased pathogenicity during the adaptation of SARS-CoV to humans.

8a and 8b proteins are distinct from ORF 8 protein in conformation ([@bib22]). In expression studies, 8a protein interacts with S protein and 8b protein interacts with M, E, 3a and 7a proteins, while ORF 8 protein interacts with S, 3a and 7a proteins. 8b protein expression significantly down-regulated the E protein level, while the E gene mRNA level was apparently not affected ([@bib22]). However, the biological function of 8a and 8b proteins is not known in the context of virus replication.

SARS-CoV 9b protein is expressed from an internal ORF in the N gene. The expression of 9b protein was demonstrated in infected cells using immunohistochemical analysis ([@bib3]). The crystal structure of 9b protein revealed a novel dimeric tent-like β structure with an amphipathic surface and a central hydrophobic cavity, which binds lipid molecules that probably allows its association with intracellular vesicles. ([@bib34]). The precise function of 9b protein is still not understood, although it is proposed that 9b protein might contribute to virus assembly as a membrane-attachment point for other viral proteins, like N protein ([@bib34]).

3. Conclusions
==============

The accumulation of novel information about the diverse biological functions of SARS-CoV accessory proteins has raised some interesting ideas and questions about their role in SARS-CoV pathogenesis. As most of the studies are performed using protein expressions in cell culture systems, it is imperative to validate these biological functions in the context of virus replication and pathogenesis in relevant animal models. As a first step in this direction, Yount et al. examined the role of SARS-CoV accessory proteins in virus replication in mice ([@bib61]). Yount et al. showed that infection of six-week-old female BALB/c mice with the Urbani strain-derived infectious clone of SARS-CoV or its accessory gene deletion mutants resulted in no difference in virus titers in the lung at 2 days post-infection ([@bib61]). However, it must be noted that this is not an ideal animal model for SARS disease because intranasal inoculation of SARS-CoV into mice results in SARS-CoV replication in the lung with no clinical signs and symptoms of SARS ([@bib49], [@bib50]). A recent study showed that infection of BALB/c mice with a mouse-adapted SARS-CoV (Urbani strain) resulted in a lethal infection that reproduces the clinical signs and pulmonary pathology observed in severe human cases of SARS ([@bib40]). Furthermore, two groups have independently developed an animal model for lethal infection of SARS-CoV using transgenic mice that express the functional SARS-CoV receptor, ACE2 ([@bib33], [@bib58]). Progress in this area was bolstered by the publication of a report by Rockx et al. that showed the development of two novel lethal SARS-CoV infection models in aged mice using recombinant SARS-CoV that express the spike (S) glycoprotein variants from an early human isolate and palm civet isolate ([@bib41]). Mice infected with these lethal S glycoprotein variants of SARS-CoV developed ARDS and the pathological symptoms were very similar to the pathology observed in acute human cases of SARS ([@bib41]). These exciting advances in the field combined with the availability of the reverse genetics system for SARS-CoV ([@bib2], [@bib60]) provide us the tools to investigate the role of accessory proteins in the SARS-CoV life cycle and address some key questions:1.What is the importance of virion-associated SARS-CoV accessory proteins, 3a, ORF 6, 7a and 7b, in the virus life cycle?2.What is the role of the individual accessory proteins in determining the outcome of lethal SARS-CoV infection in animal models? Are the SARS-CoV accessory gene deletion mutants less virulent and if so, which accessory gene(s) is responsible for attenuation?3.Are the deletion mutants of ORF 3b and ORF 6 more sensitive to IFN-induced inhibition of SARS-CoV infection in vitro? What is the mechanism of IFN signaling inhibition by 3b protein?4.Does the IFN antagonizing activity of 3b and ORF 6 proteins play a significant role in modulating SARS-CoV replication and/or pathogenesis in animal models? Has SARS-CoV evolved with multiple IFN antagonizing proteins for its survival and propagation in different susceptible hosts?5.What is the contribution of accessory genes in the up-regulation of pro-inflammatory cytokine and chemokine production in infected cells and animals? Are the deletion mutants of SARS-CoV ORFs 3a and 7a significantly impaired in inducing pro-inflammatory cytokine responses in infected cells and/or animals and if so, how does it alter the disease progression in infected animals?

Answers to some of these questions will bring us closer towards deciphering the role of these accessory genes in the coronavirus life cycle and provide valuable information that will elucidate the molecular mechanism of pathogenesis and propagation of SARS-CoV in nature.
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